Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
Volume 0.37M
Average 0.43M
ODTX Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
Revenue history
Currency unavailable · from the income statement
No Revenue data reported for this period type.
Revenue vs competitors
How ODTX compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Jun 2026 | $281.99M USD | +34.8% | +20.1% | |
| LTM Mar 2026 | $232.39M USD | +107.7% | +183.6% | |
| LTM Sep 2026 | $90.49M USD | — | — | |
| LTM Mar 2026 | $8.37M USD | -52.9% | -35.9% | |
ALMSAlumis Inc. Common Stock | LTM Jun 2026 | $7.4M USD | -63.1% | — |
ORKAOruka Therapeutics, Inc. | LTM Sep 2026 | $0 USD | — | — |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | FY2024 | €0 EUR | — | — |
| LTM Mar 2026 | $0 USD | — | — | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — |
| Peer median (excluding ODTX) | — | -9.1% | +20.1% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.